INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines tohelp treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate in a virtual fireside chat at the upcoming Stephens Biotechnology Virtual Fireside Chat Conference. During the conference, members of INOVIO's management team will also be conducting one-on-one meetings with investors.
https://mma.prnewswire.com/media/2310866/INOVIO_v1_Logo.jpg
Date: November 4, 2025Time: 3:00-3:50pm ETFormat: Virtual fireside chat
There will not be a replay or transcript of the call(s). To join the meetings or to obtain more information, please contact your Stephens representative.
About INOVIOINOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.
ContactsMedia: Jennie Willson, (267) 429-8567, communications@inovio.comInvestors: Peter Vozzo, ICR Healthcare, (443) 213-0505,investor.relations@inovio.com
https://edge.prnewswire.com/c/img/favicon.png?sn=PH05802&sd=2025-10-23
View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-the-stephens-biotechnology-virtual-fireside-chat-conference-302593182.html
SOURCE INOVIO Pharmaceuticals, Inc.
https://rt.newswire.ca/rt.gif?NewsItemId=PH05802&Transmission_Id=202510231605PR_NEWS_USPR_____PH05802&DateId=20251023